278 related articles for article (PubMed ID: 26893557)
21. Induction of Au-methotrexate conjugates by sugar molecules: production, assembly mechanism, and bioassay studies.
Wang WY; Zhao XF; Ju XH; Liu P; Li J; Tang YW; Li SP; Li XD; Song FG
Int J Pharm; 2018 Mar; 538(1-2):65-78. PubMed ID: 29341908
[TBL] [Abstract][Full Text] [Related]
22. The effect of the substitution level of some dextran-methotrexate conjugates on their antitumor activity in experimental cancer models.
Nevozhay D; Budzynska R; Jagiello M; Kanska U; Omar MS; Opolski A; Wietrzyk J; Boratynski J
Anticancer Res; 2006; 26(3A):2179-86. PubMed ID: 16827162
[TBL] [Abstract][Full Text] [Related]
23. Toxicity evaluation of magnetic hyperthermia induced by remote actuation of magnetic nanoparticles in 3D micrometastasic tumor tissue analogs for triple negative breast cancer.
Stocke NA; Sethi P; Jyoti A; Chan R; Arnold SM; Hilt JZ; Upreti M
Biomaterials; 2017 Mar; 120():115-125. PubMed ID: 28056401
[TBL] [Abstract][Full Text] [Related]
24. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics.
Garg NK; Singh B; Jain A; Nirbhavane P; Sharma R; Tyagi RK; Kushwah V; Jain S; Katare OP
Colloids Surf B Biointerfaces; 2016 Oct; 146():114-26. PubMed ID: 27268228
[TBL] [Abstract][Full Text] [Related]
25. Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: An approach towards enhanced attenuation of tumor.
Singh A; Jain S; Sahoo SK
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110695. PubMed ID: 32204010
[TBL] [Abstract][Full Text] [Related]
26. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate loaded on magnetite iron nanoparticles coated with chitosan: Biosynthesis, characterization, and impact on human breast cancer MCF-7 cell line.
Ali EMM; Elashkar AA; El-Kassas HY; Salim EI
Int J Biol Macromol; 2018 Dec; 120(Pt A):1170-1180. PubMed ID: 30172815
[TBL] [Abstract][Full Text] [Related]
28. In Vitro and In Vivo Efficacy of a Novel Glucose-Methotrexate Conjugate in Targeted Cancer Treatment.
Woźniak M; Pastuch-Gawołek G; Makuch S; Wiśniewski J; Krenács T; Hamar P; Gamian A; Szeja W; Szkudlarek D; Krawczyk M; Agrawal S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572433
[TBL] [Abstract][Full Text] [Related]
29. The Synergistic Effect of Hyperthermia and Chemotherapy in Magnetite Nanomedicine-Based Lung Cancer Treatment.
Yang SJ; Huang CH; Wang CH; Shieh MJ; Chen KC
Int J Nanomedicine; 2020; 15():10331-10347. PubMed ID: 33376324
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
Ma D; Huang H; Moscow JA
Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
[TBL] [Abstract][Full Text] [Related]
31. Fullerenol-Based Intracellular Delivery of Methotrexate: A Water-Soluble Nanoconjugate for Enhanced Cytotoxicity and Improved Pharmacokinetics.
Bahuguna S; Kumar M; Sharma G; Kumar R; Singh B; Raza K
AAPS PharmSciTech; 2018 Apr; 19(3):1084-1092. PubMed ID: 29159749
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and properties of a biodegradable polymer-drug conjugate: Methotrexate-poly(glycerol adipate).
Suksiriworapong J; Taresco V; Ivanov DP; Styliari ID; Sakchaisri K; Junyaprasert VB; Garnett MC
Colloids Surf B Biointerfaces; 2018 Jul; 167():115-125. PubMed ID: 29631222
[TBL] [Abstract][Full Text] [Related]
33. Controlled release of methotrexate from w/o microemulsion and its in vitro antitumor activity.
Karasulu HY; Karabulut B; Göker E; Güneri T; Gabor F
Drug Deliv; 2007 Apr; 14(4):225-33. PubMed ID: 17497355
[TBL] [Abstract][Full Text] [Related]
34. Preparation and Characterization of Fe
Dai X; Yao J; Zhong Y; Li Y; Lu Q; Zhang Y; Tian X; Guo Z; Bai T
Int J Nanomedicine; 2019; 14():9647-9663. PubMed ID: 31824157
[TBL] [Abstract][Full Text] [Related]
35. A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery.
Lodhi MS; Khalid F; Khan MT; Samra ZQ; Muhammad S; Zhang YJ; Mou K
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011493
[TBL] [Abstract][Full Text] [Related]
36. In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma.
Ray S; Saha S; Sa B; Chakraborty J
Drug Deliv Transl Res; 2017 Apr; 7(2):259-275. PubMed ID: 28050892
[TBL] [Abstract][Full Text] [Related]
37. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
[TBL] [Abstract][Full Text] [Related]
38. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
Ofner CM; Pica K; Bowman BJ; Chen CS
Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
[TBL] [Abstract][Full Text] [Related]
39. Antitumor properties and toxicity of dextran-methotrexate conjugates are dependent on the molecular weight of the carrier.
Nevozhay D; Budzynska R; Kanska U; Jagiello M; Omar MS; Boratynski J; Opolski A
Anticancer Res; 2006; 26(2A):1135-43. PubMed ID: 16619515
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization and in vitro antitumor activity evaluation of hyaluronic acid-alendronate-methotrexate nanoparticles.
Gao C; Wang M; Zhu P; Yan C
Int J Biol Macromol; 2021 Jan; 166():71-79. PubMed ID: 33091477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
